Kuehn Law, PLLC is investigating whether certain officers and directors of Immunovant, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages for shareholders and changes in corporate governance. Long-term Immunovant stockholders are encouraged to contact the law firm for a free consultation, as there may be limited time to act. The investigation highlights concerns over management integrity affecting shareholder value and market fairness.
Rapid Dose Therapeutics announced it will issue common shares to settle $142,067.63 of accrued interest on its secured convertible notes by October 15, 2026. The notes, originally issued in 2023, bear 18% annual interest payable quarterly in shares a...
JP Morgan has put Unilever on positive watch and Haleon on negative watch ahead of the third-quarter earnings reports from European consumer staples companies. The broker also favors Givaudan, Heineken, and Danone, particularly in beer, ingredients, ...
Intel shares fell 4% after Elon Musk confirmed discussions with Taiwan Semiconductor Manufacturing (TSMC) about joining Terafab, a Texas chip venture where Intel is currently the sole manufacturing partner. This potential partnership could reduce Int...
Micron's stock short volume ratio surged to 55.34 on October 2, marking a two-week high and signaling more bearish bets than bullish for the first time in that period. This rise coincides with market volatility following Micron's September 30 earning...
Omai Gold Mines Corp. has filed a National Instrument 43-101 Technical Report supporting its Preliminary Economic Assessment for the Wenot Open Pit and Gilt Underground deposits in Guyana. The report projects an average annual gold production of appr...
